Preimplantation Genetic Diagnosis – Modern Medicine and Your Path to Parenthood
As women age, the risk of chromosomal abnormalities in eggs increases, reducing pregnancy success and raising the risk of miscarriage. Preimplantation Genetic Testing for Aneuploidies (PGT-A), an innovative form of PGD, helps identify healthy embryos during IVF, significantly improving your chances of a successful pregnancy.
What is PGT-A and How Can it Help?
PGT-A tests embryos for chromosomal abnormalities to ensure only those with the correct chromosome number (euploid) are selected for transfer. This method enhances the chances of success, especially for couples with a longer fertility journey or multiple failed IVF attempts.
The PGT-A Process
After fertilization, embryos develop to the blastocyst stage (day 5 – 6). A small sample from the outer cell layer (trophectoderm, will later grow into the placenta) is taken and tested for chromosomal issues like Down Syndrome and others. Euploid embryos are then chosen for transfer, improving the likelihood of a successful pregnancy.
Treatments for International Patients at the 360° Fertility Center Zurich
Innovative Treatment: Switzerland’s modern legislation supports treatments like PGT-A to be performed without bureaucratic hurdles, significantly increasing the chances of success.
Excellent Medical Standards: Swiss healthcare provides state-of-the-art technology and experienced specialists, ensuring the highest quality of treatment.
Efficient and Convienient: Minimized stay, personalized treatment and streamlined processes. And Zürich is easily accessible by train, car or plane.
Why Choose PGT-A?
This method offers numerous advantages, particularly for women over 35 or couples who have already undergone multiple unsuccessful IVF attempts.
By selecting euploid embryos, the risk of miscarriage is significantly reduced.
Fewer IVF cycles are needed, saving both time and money.
Studies show 98.1% of couples achieving success within five transfers.
«Thanks to PGT-A and our expertise at the 360° Fertility Center, we can provide you with the best conditions for a successful pregnancy.»
Frequently Asked Questions (FAQs)
PGT-A (Preimplantation Genetic Testing for Aneuploidies) is an advanced method used in in-vitro fertilization (IVF). During this process, embryos are genetically tested to detect chromosomal abnormalities. Only healthy embryos are selected for transfer, which increases the chances of a successful pregnancy and reduces the risk of miscarriage.
We offer flexible care for all patients. You can have initial consultations conveniently via video call, and we create personalized treatment plans tailored to your schedule and needs.
The success rates vary depending on individual factors such as age and health condition. However, studies show that PGT-A significantly increases the chances of a successful pregnancy per transfer cycle, as only genetically healthy embryos are selected. This method offers substantial benefits, particularly for older patients or those who have experienced repeated miscarriages.
We are happy to assist you with communication with your insurance provider and provide you with the necessary documentation. We recommend checking with your insurance in advance to clarify the extent of coverage for the treatment costs.
The duration of the treatment depends on various factors, including preparation and the number of IVF cycles. After the legally required waiting period, the entire process typically takes about 6-8 weeks until the embryo transfer, in the best-case scenario.